NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
Post-LOEnorethindrone acetate and ethinyl estradiol
ANDAORAL-21TABLET
Approved
Jan 2016
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
3/8 — Basic
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL (norethindrone acetate and ethinyl estradiol) by Ichnos Glenmark Innovation is estrogen receptor agonists [moa]. Approved for estrogen [epc]. First approved in 2016.
Drug data last refreshed 20h ago
Mechanism of Action
Estrogen Receptor Agonists
Pharmacologic Class:
Estrogen
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL at Ichnos Glenmark Innovation? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.